Yesterday
500th Ep Bonus AMA: Diabetes Meds, AI in Medicine, Thyroid Antibodies, Sleep Meds, Top 5 Lists, Favorite Failures, and More!
In this bonus episode, Matt and Paul answer Patreon listener questions on various topics, including the role of AI in medicine, concerns about antibiotics and their impact on health, insomnia treatments, thyroid health, reflections on career burnout and more. They also share pers ... Show More
49m 22s
Oct 6
#500: COPD Update with Cyrus Askin
GOLD Updates, Novel Treatments, and Managing Comorbidities in COPD Care Level up your COPD care with practical, evidence-based strategies. Learn how to confirm airflow obstruction with spirometry (and use LLN/Z-scores thoughtfully), stage patients with the A/B/E framework, and bu ... Show More
1h 22m
Nov 2022
190. What a cardiologist thinks of my cholesterol, with Michael Twyman, MD
This week, Paul interviews board certified cardiologist, Michael Twyman. Michael comments on Paul’s blood lipids and they both chat about apoB, cardiovascular risks, oxidized LDL, and, of course, seed oils. They both share what they believe the true indicators of cardiovascular r ... Show More
1h 29m
Jul 8
How to Prevent Heart Disease with Mitochondria, Muscle, and the Endothelial Glycocalyx | Dr. Michael Twyman
Did you know every 40 seconds someone in the U.S. has a heart attack—and 1 in 5 never even see it coming? This week, I am joined by preventive cardiologist Dr. Michael Twyman as we discuss cutting-edge diagnostics, the endothelial glycocalyx, nitric oxide biology, and why muscle ... Show More
1h 43m
Sep 12
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More
31m 5s
Jul 28
Epidemiology and Outcomes in HFimpEF | JACC Deep Dive
In this JACC Deep Dive, Editor-in-Chief Harlan M. Krumholz, MD, SM, discusses a large real-world study by Min et al. examining heart failure with improved ejection fraction (HFimpEF) in over 24,000 patients. The study found that while EF improvement is common (30%), true remissio ... Show More
8m 31s